Literature DB >> 21454204

Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.

Luca Arcaini1, Marzia Varettoni, Emanuela Boveri, Ester Orlandi, Sara Rattotti, Silvia Zibellini, Michele Merli, Marco Lucioni, Silvia Rizzi, Manuel Gotti, Lucia Morello, Cristiana Pascutto, Marco Paulli.   

Abstract

We studied 122 patients with Waldenström's macroglobulinemia (WM) and 98 with splenic marginal zone lymphoma (SMZL); 29 SMZL patients (30%) had a serum MC (IgM in 17 patients). SMZL differed from WM for female prevalence, abdominal and superficial adenopathy, spleen and liver involvement, positive HCV. The median MC level was 2.0 g/dL in WM and 0.95 g/dL in SMZL (P<.001). On BM histology, SMZL was characterized by sinusoidal infiltration (70% of cases) and by a more frequent nodular pattern (P<.01) while WM had a higher incidence of interstitial BM localization. After a median follow-up of 5.3 years, median OS was not reached for SMZL and was 12 years for WM (P=.23; 14 years for asymptomatic WM, 8 years for symptomatic WM). In conclusion, despite similar outcomes of these 2 entities, SMZL appears as a disease with distinct clinical features and BM histology and a peculiar association with HCV infection.

Entities:  

Mesh:

Year:  2011        PMID: 21454204     DOI: 10.3816/CLML.2011.n.020

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


  7 in total

1.  Splenic marginal zone lymphoma masquerading as cirrhotic hypersplenism for seven years.

Authors:  John Alfred Carr
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

2.  Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.

Authors:  Lian Xu; Zachary R Hunter; Nicholas Tsakmaklis; Yang Cao; Guang Yang; Jie Chen; Xia Liu; Sandra Kanan; Jorge J Castillo; Yu-Tzu Tai; James L Zehnder; Jennifer R Brown; Ruben D Carrasco; Ranjana Advani; Jean M Sabile; Kimon Argyropoulos; M Lia Palomba; Enrica Morra; Alessandra Trojani; Antonino Greco; Alessandra Tedeschi; Marzia Varettoni; Luca Arcaini; Nikhil M Munshi; Kenneth C Anderson; Steven P Treon
Journal:  Br J Haematol       Date:  2015-12-13       Impact factor: 6.998

Review 3.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

Review 4.  Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.

Authors:  Luca Arcaini; Michele Merli; Stefano Volpetti; Sara Rattotti; Manuel Gotti; Francesco Zaja
Journal:  Clin Dev Immunol       Date:  2012-08-26

Review 5.  Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy.

Authors:  Syed Tasleem; Gagan K Sood
Journal:  J Clin Transl Hepatol       Date:  2015-06-15

Review 6.  Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.

Authors:  Michele Merli; Giuseppe Carli; Luca Arcaini; Carlo Visco
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

7.  Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia.

Authors:  Ari Ahn; Chan Jeoung Park; Young Uk Cho; Seongsoo Jang; Eul Ju Seo; Jung Hee Lee; Dok Hyun Yoon; Cheolwon Suh
Journal:  Ann Lab Med       Date:  2020-05       Impact factor: 3.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.